A pilot trial of Saccharomyces boulardii in ulcerative colitis

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

2000 • 1,505 citations

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial

1999 • 1,106 citations

A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease

1994 • 846 citations

Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis

1997 • 780 citations

Saccharomyces boulardii in maintenance treatment of Crohn's disease.

2000 • 698 citations

An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin.

1996 • 302 citations

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients

1997 • 261 citations

Long-term treatment of ulcerative colitis with ciprofloxacin: A prospective, double-blind, placebo-controlled study

1998 • 232 citations

Bacteria as the cause of ulcerative colitis

2001 • 221 citations

Probiotics and Inflammatory Bowel Disease: Is There a Scientific Rationale?

2000 • 204 citations

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1994 • 164 citations

Prevention of further recurrences ofClostridium difficile colitis withSaccharomyces boulardii

1990 • 74 citations

Probiotics and inflammatory bowel disease: Is there a scientific rationale?

2007 • 65 citations